What does SwiftPharma do?

SwiftPharma develops plant-produced recombinant proteins for life-science research. We use plants as biofactories to produce proteins that researchers use to study biological processes and develop cell-based research models.

How does the HyperXpress® platform work?

Our HyperXpress® platform uses transient expression: we introduce genetic instructions into plant cells, enabling them to produce a specific protein. The protein is then extracted and purified for its intended research application.

Can plants produce complex human proteins with the right post-translational modifications?

Yes. Plants are eukaryotic organisms and possess cellular machinery that supports protein folding and post-translational modifications (PTMs), including disulfide bond formation, glycosylation and phosphorylation. These capabilities enable the production of complex human proteins. Through targeted engineering, selected modifications can also be fine-tuned — for example, by reducing plant-specific sugar structures and introducing enzymes that support human-like glycosylation. At SwiftPharma, our glycoengineered plant lines support this approach. Because plant and human modification pathways are not identical, the required modifications and biological activity must be assessed for each protein.

Which recombinant proteins will SwiftPharma offer?

Our catalogue is being developed around cytokines, growth factors and extracellular matrix proteins for life-science research. Product launches will be phased, with our portfolio evolving in response to research needs and customer feedback. Contact us for the latest information on specific proteins and availability.

What does “Research Use Only” mean?

Research Use Only (RUO) means that our proteins are intended for laboratory research. They are not intended for diagnostic procedures or therapeutic administration. Please consult the product documentation to determine whether a protein is suitable for your planned research application.

Can I evaluate a SwiftPharma protein before ordering?

Contact us to discuss your application and interest in evaluating a product. Sample availability depends on the protein’s development stage and available stock. We will confirm the available options and timing so you can plan your experiments accordingly.

My question isn’t listed here — can I still ask it?

Absolutely. Use the contact form at the bottom of this page to submit your question — it goes directly to hello@swiftpharma.eu, and our team will get back to you personally.

Your Innovation Partner

Life through
leavesleaves

Biology is the most advanced manufacturing technology on the planet. We program plants into low-cost bioreactors to produce animal-free proteins, fast and scalable.

Explore the platform Contact us

Scroll

Antibodies·Vaccines·Cytokines·Enzymes·Hormones·Ligands·Growth Factors·Scaffold Proteins·Fusion Proteins·

Our mission

At SwiftPharma, we say NO to animals in biotechnology. Using plants as mini-bioreactors, we set a new standard for sustainable health, for our planet, and for mankind.

Nicotiana benthamiana · syringe infiltration · Agrobacterium suspension OD₆₀₀ 0.4

Our Manufacturing Workflow

Genetic code in.
Purified protein out.

Our HyperXpress technology leverages an efficient and sustainable process to produce high-quality proteins derived from plants. The platform integrates cutting-edge technologies to optimize performance and scalability. Together, these innovations enable a transformative, plant-based approach to biologic manufacturing that surpasses traditional limitations.

Upstream process

Downstream process

From gene to purified protein in as little as 6 weeks

Any scale

Any challenge

The Problem

Eliminating current
manufacturing bottlenecks.

Legacy biomanufacturing can't keep pace with demand. Six constraints define the ceiling — and each one is what our platform is built to remove.

Industry Challenges

SwiftPharma's Solution

01 / Animal-free

Animal-derived inputs hold back more ethical research

As biotechnology moves towards reducing reliance on animals, animal-derived materials bring ethical concerns, variability and traceability challenges. The sector needs alternatives that support greener, more responsible research.

The Answer

Plant-based production supporting animal-free research

SwiftPharma’s platform is designed to eliminate animal-derived production ingredients, reducing dependence on animal sources and supporting the transition towards more sustainable, cruelty-free research practices.

02 / Complexity

Simple expression systems fall short on complex proteins

Missing modifications or incorrect folding can compromise biological activity and limit which human proteins an expression system can deliver.

The Answer

Complex human proteins, powered by plant biology

Our plants combine eukaryotic folding and modification machinery with targeted glycoengineering, enabling complex protein production and fine-tuning of selected sugar structures towards human-like profiles.

03 / Safety

Biological contaminants can undermine research results

Host-derived impurities and contaminants can interfere with sensitive assays, waste valuable samples and put experimental conclusions at risk.

The Answer

A safety advantage built into the production host

Plant production avoids mammalian cell substrates, reducing concerns associated with mammalian viral contaminants. Purification and product-specific testing address the remaining impurity risks.

04 / Speed

Slow protein development holds research back

Lengthy cell-line development can delay access to new proteins, slow experimental progress and postpone critical decisions.

The Answer

Faster access to protein development and evaluation

HyperXpress® bypasses the need to establish a stable production cell line for every target, shortening the route from genetic sequence to protein expression.

05 / Cost

High protein costs constrain research ambition

Expensive production infrastructure and complex processing drive costs that can restrict experimental scope and strain research budgets.

The Answer

Plant-based efficiency for more accessible research proteins

Our platform reduces reliance on capital-intensive cell-culture bioreactors, creating opportunities to lower production costs and offer competitively priced RUO proteins.

06 / Scale

Rigid production capacity struggles to keep pace

Expanding conventional production can demand major equipment investments and lengthy facility upgrades, limiting flexibility as demand grows.

The Answer

Modular growth with flexible upstream capacity

SwiftPharma can expand upstream production by increasing plant biomass, offering a flexible alternative to larger cell-culture vessels. Extraction and purification capacity scale alongside production.

HelioKine rhFGF-2 TR recombinant protein vial

Protein portfolio highlights

One platform. Endless possibilities.

On a regular basis throughout the year, new research-use-only (RUO) proteins are added to our portfolio. Categorised by biological function, HelioKine™ proteins are organised in classes to simplify selection, guide experimental design and provide a clear, intuitive framework for navigating diverse protein families.

HelioKine^™ AF

Attachment Factors

Surface and matrix proteins for cell adhesion and scaffold coating.

HelioKine^™ IL

Interleukins

Immune signalling mediators for cell culture and assay work.

HelioKine^™ CX

Chemokines

Chemotactic ligands driving migration and trafficking studies.

HelioKine^™ IF

Interferons

Antiviral and immunomodulatory cytokines with native folding.

HelioKine^™ IM

Immune-Modulators

Checkpoint and co-stimulatory proteins for immunology research.

HelioKine^™ GF

Growth Factors

Cysteine-rich regulators for expansion and differentiation protocols.

HelioKine^™ EZ

Enzymes

Catalytic proteins for processing, dissociation and reaction workflows.

HelioKine^™ TF

Transcription Factors

DNA-binding regulators for reprogramming and gene-expression studies.

COL1COL3SpidroCollaneEGFbFGFFGF4FGF9FGF10VEGF-165TGF-Beta 1SCFIL-15

Interested in our first launch?

HGFR-Spondin-1EPOActivin ABMP-2NogginTNF-AlphaGFPIL-7BMP-7BMP-4

Answers

Frequently
asked.

Quick answers on the HyperXpress® platform, protein quality, RUO material, and samples. Need something specific? Ask Root, our AI agent, in the lower-right corner.

Didn't find your answer?Contact us →

Codon Optimization · Live

Every gene, tuned for plant expression.

Watch a human coding sequence get re-written codon-by-codon for expression in Nicotiana benthamiana — same protein, rebuilt in the host's preferred triplets.

UniProt

P01308

Length

110 aa

GC %

Swaps

Codons optimized000/110

ATGMGCCACTGLTGGWATGMCGCRCTGLCTGLCCCP010CTGLCTGLGCCACTGLCTGLGCCACTGLTGGWGGCGCCCP020GACDCCCPGCCAGCCAGCCATTCFGTGVAACNCAGQCACH030CTGLTGCCGGCGAGCSCACHCTGLGTGVGAGEGCCACTGL040TACYCTGLGTGVTGCCGGCGGAGECGCRGGCGTTCFTTCF050TACYACCTCCCPAAGKACCTCGCRCGCRGAGEGCCAGAGE060GACDCTGLCAGQGTGVGGCGCAGQGTGVGAGECTGLGGCG070GGCGGGCGCCCPGGCGGCCAGGCGAGCSCTGLCAGQCCCP080CTGLGCCACTGLGAGEGGCGAGCSCTGLCAGQAAGKCGCR090GGCGATCIGTGVGAGECAGQTGCCTGCCACCTAGCSATCI100TGCCAGCSCTGLTACYCAGQCTGLGAGEAACNTACYTGCC110AACN

Protein · unchanged110 aa

MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCN

·Human

·Optimized

·Cursor

Unchanged (Met / Trp)